Kengo Takeuchi
Overview
Explore the profile of Kengo Takeuchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
314
Citations
8195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sekiguchi Y, Tsutsumi H, Kudo M, Iizaki Y, Maseki N, Kawamura M, et al.
Gan To Kagaku Ryoho
. 2025 Mar;
52(2):135-140.
PMID: 40073888
The patient was a 51-year-old man who was diagnosed as having prostate cancer(adenocarcinoma)in December Year X-3. He underwent total prostatectomy in June Year X-2. The lesions were confined to the...
2.
Nakano K, Hirasawa T, Takasu A, Higashi Y, Nunobe S, Shimoda M, et al.
Digestion
. 2025 Mar;
:1-23.
PMID: 40058358
Introduction: Autoimmune gastritis (AIG), a type of chronic atrophic gastritis, is characterized by positive anti-parietal cell antibodies and mucosal atrophy predominantly in the corpus. In Japan, AIG has garnered increasing...
3.
Fujimoto A, Sakata S, Kataoka K, Kogure Y, Chiba K, Okada A, et al.
Am J Surg Pathol
. 2025 Mar;
PMID: 40026197
Programmed death-ligand 1 (PD-L1/CD274) structural variation (SV) disrupting the 3'-untranslated region has been highlighted as being associated with PD-L1 overexpression. In the present study, we evaluated lymphoma tissue samples to...
4.
Urasaki T, Ono M, Yamashita K, Tanizawa T, Togashi Y, Ohmoto A, et al.
Oncol Lett
. 2025 Jan;
29(3):108.
PMID: 39776650
sarcoma is rare and its clinical features remain unclear. Given the similarity in presentation, it is possible that previously reported cases of Ewing-like adamantinoma may have been sarcoma. The present...
5.
Ninomiya H, Togashi Y, Sugita K, Takeuchi K
Pathol Int
. 2025 Jan;
75(2):124-126.
PMID: 39776063
No abstract available.
6.
Nakajima I, Yoshino K, Miyake M, Takeuchi K, Tsuji H
Ophthalmic Plast Reconstr Surg
. 2024 Dec;
PMID: 39727237
No abstract available.
7.
Pichler A, Amador C, Fujimoto A, Takeuchi K, de Jong D, Iqbal J, et al.
Histopathology
. 2024 Dec;
86(1):119-133.
PMID: 39679758
Peripheral T cell lymphomas (PTCLs) are a biologically diverse and aggressive group of non-Hodgkin lymphomas that originate from mature T cells, often presenting with complex clinical and morphological features. This...
8.
Takagi S, Nakajima M, Koike S, Takami M, Sugiura Y, Sakata S, et al.
Oncogene
. 2024 Dec;
PMID: 39663392
Osteosarcoma (OS) is a primary malignant bone tumor primarily affecting children and adolescents. The lack of progress in drug development for OS is partly due to unidentified actionable oncogenic drivers...
9.
Hirose Y, Oba A, Takamatsu M, Hamada T, Takeda T, Suzuki T, et al.
Pancreatology
. 2024 Oct;
24(7):1021-1030.
PMID: 39395872
Background/objective: Caveolin-1 (Cav1) expressed in cancer cells (cCav1) or cancer-associated fibroblasts (fCav1) exerts either pro- or anti-tumorigenic effects depending on the cancer type or stage of cancer. We aimed to...
10.
Shigematsu Y, Kanda H, Takahashi Y, Takeuchi K, Inamura K
Virchows Arch
. 2024 Oct;
PMID: 39395054
In hepatocellular carcinoma (HCC), CD147 expression contributes to tumor malignancy; however, its relationship with the tumor-immune microenvironment (TIME) remains unclear. This study aimed to elucidate the clinicopathological characteristics associated with...